 MONTREAL and CHARLOTTE, N.C., Nov. 11, 2021 PRNewswire -- Milestone Pharmaceuticals Inc. Nasdaq: MIST, a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences: The 2021 Jefferies London Virtual Healthcare Conference. 